Presented in this report is a 66-year-old male with a widespread persistent erythema multiforme mostly atypical in appearance, which was detected well before the diagnosis of underlying extrahepatic cholangiocarcinoma. The lesions regressed in response to chemotherapy, but they appeared again in connection with tumor relapse. Clinicians should recognize persistent erythema multiforme as one of the paraneoplastic dermatoses and efforts should be made to detect internal malignancies in patients with these skin lesions.

1.
Poole S, Fenske NA: Cutaneous markers of internal malignancy. Paraneoplastic dermatoses and environmental carcinogens. J Am Acad Dermatol 1993;28:147–164.
2.
Huff JC, Weston WL, Tonnesen MG: Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 1983;8:763–775.
3.
Pavlovic MD, Karadaglic DM, Kandolf LO, Mijuskovic ZP: Persistent erythema multiforme: a report of three cases. J Eur Acad Dermatol Venereol 2001;15:54–58.
4.
Huff JC: Erythema multiforme and latent herpes simplex infection. Semin Dermatol 1992;11:207–210.
5.
Drago F, Romagnoli M, Loi A, Rebora A: Epstein-Barr virus-related persistent erythema multiforme in chronic fatigue syndrome. Arch Dermatol 1992;128:217–222.
6.
Davidson DM, Jegasothy BV: Atypical erythema multiforme: a marker of malignancy? Cutis 1980;105:465–467.
7.
Drago F, Parodi A, Rebora A: Persistent erythema multiforme: report of two new cases and review of literature. J Am Acad Dermatol 1995;33:366–369.
8.
Chapman RS, Forsyth A, MacQueen A: Erythema multiforme in association with active ulcerative colitis and Crohn’s disease. Dermatologica 1977;154:32–38.
9.
Shinojima Y, Toma Y, Terui T: Sweet syndrome associated with intrahepatic cholangiocarcinoma producing granulocyte colony-stimulating factor. Br J Dermatol 2006;155:1103–1104.
10.
Kurzrock R, Cohen PR: Cutaneous paraneoplastic syndromes in solid tumors. Am J Med 1995;99:662–671.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.